These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 14433511)

  • 1. [The copper content of some organs in Wilson's disease].
    PLOOIJ M; van der MEER ; KAAG A
    Ned Tijdschr Geneeskd; 1960 Feb; 104():324-6. PubMed ID: 14433511
    [No Abstract]   [Full Text] [Related]  

  • 2. Copper content of hair and nails in Wilson's disease (hepatolenticular degeneration).
    RICE EW; GOLDSTEIN NP
    Metabolism; 1961 Dec; 10():1085-7. PubMed ID: 14491888
    [No Abstract]   [Full Text] [Related]  

  • 3. Some properties of brain copper-proteins in hepatolenticular degeneration.
    PORTER H
    Arch Neurol; 1959 Nov; 1():544-56. PubMed ID: 14434267
    [No Abstract]   [Full Text] [Related]  

  • 4. A critical evaluation of copper metabolism in Indian Wilson's disease children with special reference to their phenotypes and relatives.
    Prasad R; Kaur G; Walia BN
    Biol Trace Elem Res; 1998 Nov; 65(2):153-65. PubMed ID: 9881519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The determination of copper in biological materials by flame spectrophotometry.
    NEWMAN GE; RYAN M
    J Clin Pathol; 1962 Mar; 15(2):181-4. PubMed ID: 14479334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wilson's disease: a new gene and an animal model for an old disease.
    Cuthbert JA
    J Investig Med; 1995 Aug; 43(4):323-36. PubMed ID: 7552582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Copper levels in the tissues of patients with Wilson's disease].
    Petrovecki V; Kovacić Z; Pizent A; Jakić-Razumović J
    Arh Hig Rada Toksikol; 1997 Jun; 48(2):241-6. PubMed ID: 9471969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatolenticular degeneration--is the term too narrow to explain Wilson's disease?
    Fatima J; Karoli R; Siddiqui Z; Chandra A; Jain V
    J Assoc Physicians India; 2014 Jun; 62(6):531-3. PubMed ID: 25856923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the stable isotope 65Cu test for the screening of Wilson's disease in a family with two affected members.
    Merli M; Patriarca M; Loudianos G; Valente C; Riggio O; De Felice G; Petrucci F; Caroli S; Attili AF
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):270-5. PubMed ID: 9759594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synovial copper deposition as a possible explanation of arthropathy in Wilson's disease.
    Kramer U; Weinberger A; Yarom R; Zoldan J; Bahar A; Godoth N
    Bull Hosp Jt Dis; 1993; 52(2):46-9. PubMed ID: 8443556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrahepatocellular localization of copper in Wilson's disease.
    Yano M; Sakamoto N; Takikawa T; Hayashi H
    Nagoya J Med Sci; 1993 Mar; 55(1-4):131-7. PubMed ID: 8247102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of ceruloplasmin and plasma copper to hepatolenticular degeneration (Wilson's disease).
    SCHEINBERG IH
    Prog Neurobiol (1956); 1956; 1():52-63. PubMed ID: 13359521
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pathogenesis and treatment of Wilson's disease].
    Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
    Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copper removal strategies for Wilson's disease crisis in the ICU.
    Reynolds HV; Talekar CR; Bellapart J; Leggett BA; Boots RJ
    Anaesth Intensive Care; 2014 Mar; 42(2):253-7. PubMed ID: 24580393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Occurrence of copper metabolism abnormalities in the families of four individuals with newly diagnosed Wilson's disease].
    Dastych M
    Vnitr Lek; 1997 Feb; 43(2):87-90. PubMed ID: 9245074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of cholecystokinin-stimulated biliary secretions reveal a high molecular weight copper-binding substance in normal subjects that is absent in patients with Wilson's disease.
    Iyengar V; Brewer GJ; Dick RD; Chung OY
    J Lab Clin Med; 1988 Mar; 111(3):267-74. PubMed ID: 3125292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Copper level and metallothionein-like Cu-binding protein in cultured skin fibroblasts from patients with Menkes' disease and Wilson's disease].
    Sato M; Hayashi A; Ito H; Tojo M; Arima M
    No To Shinkei; 1984 Nov; 36(11):1063-8. PubMed ID: 6525319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tracing copper-thiomolybdate complexes in a prospective treatment for Wilson's disease.
    Zhang L; Lichtmannegger J; Summer KH; Webb S; Pickering IJ; George GN
    Biochemistry; 2009 Feb; 48(5):891-7. PubMed ID: 19146437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [WILSON'S DISEASE (HEPATOLENTICULAR DEGENERATION, DYSTROPHIA HEPATOCEREBRALIS) DIAGNOSIS, TREATMENT AND DISPENSARY OBSERVATION. GUIDELINES WERE APPROVED BY THE XV GASTROENTEROLOGICAL SCIENTIFIC SOCIETY OF RUSSIA IN 2015].
    Golovanova EV; Lazebnik LB; Konev YV; Shaposhnikova NA
    Eksp Klin Gastroenterol; 2015; (7):108-11. PubMed ID: 26817129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.